SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (622)1/31/2005 8:31:50 AM
From: richardred  Read Replies (1) | Respond to of 7254
 
Source: BT
Date: 07:55 AM

01/31 07:55 +DJ Lannett Files Two New Drug Applications; In-Licenses Additional Two ANDA Applications And Two Drug Formulas>LCI

(MORE) Dow Jones Newswires

01-31-05 0755ET
01/31 07:56 *DJ Lannett Has 11 ANDAs Pending At FDA


(MORE) Dow Jones Newswires

01-31-05 0756ET
01/31 07:56 *DJ Lannett Pdt Line Would Nearly Double If All ANDAs Cleared


(MORE) Dow Jones Newswires

01-31-05 0756ET




To: richardred who wrote (622)2/8/2005 10:38:59 AM
From: richardred  Respond to of 7254
 
I'm going down, but not out! I suspect the reason for the earlier buyback announcement was today's earnings release. MYL also experiencing pricing pressure.



To: richardred who wrote (622)4/9/2009 12:18:55 PM
From: richardred  Read Replies (3) | Respond to of 7254
 
LCI- still holding. IMO-PRGO looks tempting for Teva. PRGO has been on my watch list for some time.

Message 25558632


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News